Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03024320 · ClinicalTrials.gov registry record · NA
Scale Up Evaluation of a Physical Activity Program for Adults With Physical Disability
A NA study, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- NA
- Development phase
- 544
- Enrollment target
NCT03024320 is a NA study that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 544 participants.
The verdict
NCT03024320, a NA study, has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- NA
- Development phase
- 544 participants
- Enrollment target
Study Summary
The study uses a theory-driven eHealth platform and innovative physical activity (PA) program referred to as movement-to-music (M2M) to deliver a customized, home-based PA intervention for adults with physical disability (PWD). Participants will be recruited through a large physical medicine and rehabilitation network of clinics specializing in treating patients with physical disability. Participants will be randomized to one of three groups: a) M2M; b) M2M plus social networking (M2Mplus); and c) attention control (AC). Participants will be followed for 48 weeks to obtain objective measures on physical activity, fitness and self-reported measures on health at four time points. The study will compare the effectiveness of M2M and M2Mplus in increasing physical activity and adherence compared to the AC group, estimate the improvements in health of M2M and M2Mplus compared to the AC group, and examine the mediators and moderators of the hypothesized treatment effect to understand for whom and how the intervention is effective. This multi-level, scalability study will strengthen our understanding of the potential benefits of eHealth to eliminate barriers to PA participation among PWD.
Interventions
- BEHAVIORAL Attention Control
- BEHAVIORAL M2M
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 544 participants |
| Start Date | 2018-04-18 |
| Est. Completion | 2022-10-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03024320
The ClinicalTrials.gov registry entry for NCT03024320 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 544 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Attention Control is the first listed.
NCT03024320 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03024320 about?
NCT03024320 is a clinical study titled "Scale Up Evaluation of a Physical Activity Program for Adults With Physical Disability". The study uses a theory-driven eHealth platform and innovative physical activity (PA) program referred to as movement-to-music (M2M) to deliver a customized, home-based PA intervention for adults with physical disability (PWD). Participants will be recruited through a large physical medicine and reh...
What is the current status of trial NCT03024320?
This trial is currently completed. It is a NA study. The enrollment target is 544 participants. The study started on 2018-04-18. Estimated completion is 2022-10-31.
What interventions are being tested in trial NCT03024320?
The interventions under investigation include: Attention Control (BEHAVIORAL), M2M (BEHAVIORAL).
Who is sponsoring clinical trial NCT03024320?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.